Who
Gwendolyn Binder
Director
Company insider
Files Form 4 as: Director, Instil Bio; President, Science & Tech., Cabaletta Bio.
In numbers
- Trades disclosed
- 64
- Buys
- 2
- Sells
- 9
- Bought
- $69K
- Sold
- $1.7M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 24 Oct 2019
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | TIL Instil Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | TIL Instil Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 2 Mar 2026filed 2 Mar 2026 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 2 Mar 2026filed 2 Mar 2026 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 21 Jan 2026filed 21 Jan 2026 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $25K11,312 at $2.19 | filing |
| 21 Jan 2026filed 21 Jan 2026 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $25K11,312 at $2.19 | filing |
| 28 May 2025filed 29 May 2025 | TIL Instil Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —66,667 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —66,667 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —29,908 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —29,908 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —125,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —160,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —176,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —176,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —130,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —145,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.